Chugai and DSP to begin trials of WT1-targeting cancer vaccine
This article was originally published in Scrip
Executive Summary
Roche's Japanese subsidiary Chugai and Dainippon Sumitomo Pharma (DSP) are to initiate a joint early clinical development programme in Japan for a peptide therapeutic vaccine for cancer.